Chemours (CC) PT Lowered to $22 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $14.46 +0.84%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 25
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 25
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $22.00 (from $26.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
- Brinker Int'l (EAT) PT Lowered to $210 at DA Davidson as Same Store Sales Expected to Normalize
- Intapp, Inc (INTA) PT Raised to $46 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
